Warning Letter — Baja Fresko Distributors Inc.
The FDA issued a Warning Letter to Baja Fresko Distributors Inc. following an inspection by the Office of Inspections and Investigations. The letter documented regulatory violations discovered at the firm's facility.
This notice affects Baja Fresko Distributors Inc., its operational management, and quality control personnel responsible for food distribution compliance.
The issuance of a Warning Letter signifies that the FDA has identified significant violations of regulatory requirements that could compromise product safety. This suggests potential deficiencies in Current Good Manufacturing Practice (CGMP) or distribution standards, which may necessitate facility-wide corrective actions and increased regulatory oversight of the company's operations.
Quality and compliance teams should conduct a comprehensive audit of facility maintenance and distribution protocols to ensure alignment with CGMP requirements. Immediate attention should be given to addressing any specific observations noted during the inspection to prevent further enforcement action.
FDA Warning Letter issued to: Baja Fresko Distributors Inc.. 03/27/2026 — Office of Inspections and Investigations. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/baja-fresko-distributors-inc-725781-03272026
Open in openFDA / FDA.gov